CM
PRAX icon

Caption Management’s Praxis Precision Medicines PRAX Stock Holding History

Caption Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.4M Hold
200,000
– – 0.38% 47
2025
Q4 		$58.9M Buy
200,000
+56,500
+39% +$10.5M 0.4% 52
2025
Q3 		$7.61M Buy
+143,500
New +$6.96M 0.06% 357
2025
Q2 		– Sell
-113,700
Closed -$4.31M – 1809
2025
Q1 		$4.31M Buy
113,700
+74,900
+193% +$4.68M 0.04% 440
2024
Q4 		$2.99M Buy
38,800
+14,400
+59% +$1.04M 0.03% 553
2024
Q3 		$1.4M Sell
24,400
-169,800
-87% -$9.17M 0.02% 684
2024
Q2 		$8.03M Buy
+194,200
New +$9.18M 0.12% 178

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Caption Management's PRAX Position: Q1 2026 in Review

Caption Management sold out of Praxis Precision Medicines (PRAX) in Q1 2026, closing a stake of 33,300 shares — an estimated $10.3M sold.

Caption Management first reported a position in PRAX in Q3 2024 and held it in 5 quarters. The position peaked at $9.81M in Q4 2025. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Caption Management reported no remaining Praxis Precision Medicines position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 33,300 Praxis Precision Medicines shares in Q1 2026, an estimated $10.3M.
  • Caption Management first reported a position in Praxis Precision Medicines in Q3 2024 and held it in 5 quarters.
  • Caption Management's Praxis Precision Medicines position peaked at $9.81M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.